澳洋健康收盘上涨2.51%，滚动市盈率51.38倍，总市值25.04亿元

Group 1 - The core viewpoint of the articles highlights the performance and market position of Aoyang Health, which has a current stock price of 3.27 yuan, reflecting a 2.51% increase, with a rolling PE ratio of 51.38 times and a total market capitalization of 2.504 billion yuan [1][2] - Aoyang Health's main business focuses on health care, including pharmaceutical logistics, medical services, and health care services, with four hospitals established in Zhangjiagang City [1] - The company has received various accolades, including being recognized as a tertiary comprehensive hospital and passing JCI re-evaluation, which enhances its reputation in the health sector [1] Group 2 - For the third quarter of 2024, Aoyang Health reported an operating income of 1.501 billion yuan, a year-on-year decrease of 7.54%, and a net profit of 38.6781 million yuan, down 2.39% year-on-year, with a sales gross margin of 13.72% [2] - In terms of industry comparison, Aoyang Health's PE ratio of 51.38 is higher than the industry average of 46.79 and the industry median of 47.81 [2] - As of September 30, 2024, Aoyang Health had 56,603 shareholders, an increase of 601 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]